Kintara Therapeutics, Inc.
KTRA
NASDAQ
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -2.32M | -2.01M | -1.02M | -2.96M | -3.34M |
| Total Depreciation and Amortization | 17.00K | 8.00K | 15.00K | 15.00K | 15.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 164.00K | 211.00K | 215.00K | 208.00K | 1.36M |
| Change in Net Operating Assets | 701.00K | -508.00K | -1.32M | 1.42M | 453.00K |
| Cash from Operations | -1.44M | -2.30M | -2.12M | -1.32M | -1.51M |
| Capital Expenditure | 0.00 | 0.00 | -20.00K | -- | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.00 | 0.00 | -20.00K | -- | 0.00 |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00 | 8.00M | 2.58M | -- | 43.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 0.00 | -2.00K | -2.00K | -2.00K | -2.00K |
| Other Financing Activities | -- | -- | -- | -- | -43.00K |
| Cash from Financing | 0.00 | 7.99M | 2.58M | -2.00K | -2.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.44M | 5.69M | 442.00K | -1.32M | -1.51M |
